Bisoprolol Fumarate IP/USP/EP/BP (CAS NO : 104344-23-2)

Bisoprolol Fumarate (CAS 104344-23-2) stands as a foundational cardioselective beta-1 adrenergic blocker in the United States API intermediates market, where a Pharma/API purity 99% is strictly required to meet the rigorous monograph standards of the USP and ensure the efficacy of antihypertensive formulations. Bisoprolol hemifumarate serves as a vital component for domestic high purity fine chemicals production, particularly as US-based CDMOs expand their custom synthesis services to address the increasing demand for cardiovascular therapies amidst a strategic push toward domestic manufacturing self-reliance. (RS)-1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethoxy)amino]-2-propanol fumarate is increasingly sought after by top-tier bulk chemical supplier entities to navigate complex global sourcing shifts, ensuring that General Industry purity 98% is maintained for preliminary process stages while adhering to the stringent regulatory frameworks established by the American Chemical Society and the FDA. We are an established Bisoprolol Fumarate api supplier with >= 99% purity for semi-finished formulators in the united states , providing comprehensive analytical (HPLC/NMR/MS) and supporting (Bisoprolol Fumarate) COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities